Raymond James & Associates’s Barings Corporate Investors MCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$415K Sell
20,848
-2,069
-9% -$38.3K ﹤0.01% 3212
2024
Q2
$427K Buy
22,917
+131
+0.6% +$2.34K ﹤0.01% 3163
2024
Q1
$392K Buy
22,786
+4
+0% +$73 ﹤0.01% 3215
2023
Q4
$420K Buy
22,782
+993
+5% +$16.5K ﹤0.01% 3059
2023
Q3
$347K Buy
21,789
+14
+0.1% +$215 ﹤0.01% 3106
2023
Q2
$324K Buy
21,775
+97
+0.4% +$1.37K ﹤0.01% 3206
2023
Q1
$307K Sell
21,678
-1,913
-8% -$27.1K ﹤0.01% 3229
2022
Q4
$329K Sell
23,591
-1,915
-8% -$25.8K ﹤0.01% 3157
2022
Q3
$330K Buy
25,506
+582
+2% +$8.08K ﹤0.01% 3122
2022
Q2
$334K Buy
24,924
+72
+0.3% +$1.02K ﹤0.01% 3159
2022
Q1
$378K Sell
24,852
-47,438
-66% -$738K ﹤0.01% 3250
2021
Q4
$1.16M Buy
72,290
+4,860
+7% +$77.5K ﹤0.01% 2530
2021
Q3
$1.05M Buy
67,430
+62
+0.1% +$954 ﹤0.01% 2557
2021
Q2
$1.02M Sell
67,368
-6,654
-9% -$98.6K ﹤0.01% 2577
2021
Q1
$1.03M Sell
74,022
-3,984
-5% -$53.9K ﹤0.01% 2489
2020
Q4
$1.03M Sell
78,006
-20,101
-20% -$256K ﹤0.01% 2329
2020
Q3
$1.23M Sell
98,107
-24,769
-20% -$327K ﹤0.01% 2055
2020
Q2
$1.65M Buy
122,876
+58,711
+92% +$779K ﹤0.01% 1847
2020
Q1
$745K Buy
64,165
+6,128
+11% +$94.9K ﹤0.01% 2165
2019
Q4
$979K Buy
58,037
+4,062
+8% +$68K ﹤0.01% 2281
2019
Q3
$910K Buy
53,975
+4,791
+10% +$77.8K ﹤0.01% 2246
2019
Q2
$770K Buy
49,184
+6,455
+15% +$101K ﹤0.01% 2369
2019
Q1
$661K Buy
42,729
+20,191
+90% +$314K ﹤0.01% 2474
2018
Q4
$331K Buy
22,538
+1,441
+7% +$21.7K ﹤0.01% 2797
2018
Q3
$323K Buy
21,097
+4
+0% +$61 ﹤0.01% 2975
2018
Q2
$319K Buy
21,093
+9,937
+89% +$151K ﹤0.01% 2980
2018
Q1
$168K Buy
11,156
+38
+0.3% +$573 ﹤0.01% 3182
2017
Q4
$170K Buy
+11,118
New +$175K ﹤0.01% 3113
2017
Q3
Sell
-15,618
Closed -$236K 3461
2017
Q2
$236K Hold
15,618
﹤0.01% 2884
2017
Q1
$238K Hold
15,618
﹤0.01% 2827
2016
Q4
$242K Buy
+15,618
New +$258K ﹤0.01% 2780

Other funds holding MCI

Raymond James & Associates's MCI Position: Q3 2024 in Review

Raymond James & Associates reduced its Barings Corporate Investors (MCI) stake by 9% in Q3 2024, selling an estimated $38.3K and leaving 20,848 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #3212.

Raymond James & Associates first reported a position in MCI in Q4 2016 and has held it in 31 quarters since. The position peaked at $1.65M in Q2 2020. 55 funds tracked by Wall St. Rank hold MCI as of Q3 2024.

  • Raymond James & Associates held 20,848 shares of Barings Corporate Investors worth $415K as of Q3 2024.
  • Raymond James & Associates sold 2,069 Barings Corporate Investors shares in Q3 2024, an estimated $38.3K.
  • Barings Corporate Investors made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3212 holding.
  • Raymond James & Associates first reported a position in Barings Corporate Investors in Q4 2016 and has held it in 31 quarters since.
  • Raymond James & Associates's Barings Corporate Investors position peaked at $1.65M in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.